![]() Treating Hypertension to Reduce the Incidence of HF: Recommendation e149ĩ.5.2. Pharmacological Treatment for Stage C HF pEF: Recommendations e146ĩ.5.1. Renin-Angiotensin System Inhibition With Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker or ARNI: Recommendations e144ħ.3.2.11. Pharmacological Treatment for Stage C HF With Reduced Ejection Fraction: Recommendations e144ħ.3.2.10. Biomarkers for Prognosis or Added Risk Stratification: Recommendations e142ħ.3.2. Biomarkers for Diagnosis: Recommendation e142Ħ.3.3. Biomarkers for Prevention: Recommendation e142Ħ.3.2. Initial and Serial Evaluation of the HF Patient e141Ħ.3.1. ![]() ![]() Customer Service and Ordering Informationġ.1 Methodology and Evidence Reviewe e140ġ.2.Stroke: Vascular and Interventional Neurology. ![]() Journal of the American Heart Association (JAHA).Circ: Cardiovascular Quality & Outcomes.Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |